Brook K Baker
Biographic Data
| ID | 6636336 |
|---|---|
| NAME | Brook K Baker |
| GIVEN NAMES | Brook K |
| FAMILY NAME | Baker |
| SIGNATURE | BAKER B K |
| AFFILIATIONS | Northeastern University |
| VERIFIED | No |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Pandemic preparedness and response
Nationalism has trumped solidarity, resulting in unnecessary loss of life and inequitable access to vaccines and therapeutics. Existing intellectual property (IP) regimens, trade secrets and data rights, under which pharmaceutical firms operate, have also posed obstacles to increasing manufacturing capacity, and ensuring adequate supply, affordable pricing, and equitable access to COVID-19 vaccines and other health products in low-income and midd…
A pandemic treaty for equitable global access to medical countermeasures
Pandemic, Need to know, Biotechnology and Related Fields, Science, Research, and Medicine, Biomedical Ethics and Regulation
Evolving Human Rights and the Science of Antiretroviral Medicine
Recent years have seen significant advances in the science of using antiretroviral medicines (ARVs) to fight HIV. Where not long ago ARVs were used late in disease to prevent sick people from dying, today people living with HIV can use ARVs to achieve viral suppression early in the course of disease. This article reviews the mounting new scientific evidence of major clinical and prevention ARV benefits. This has changed the logic of the AIDS resp…
Using global health initiatives to strengthen health systems
Research into the effects of global health initiatives (GHIs) on health systems has largely left out the viewpoints and contributions of civil society. This study details civil society's perspective regarding the effects of two GHIs, the US President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), on country health systems and the added value of civil society interacting with GHIs to …
Patents, Pricing, and Access to Essential Medicines in Developing Countries
A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit
The 'diagonal' approach to Global Fund financing
BACKGROUND: The potentially destructive polarisation between 'vertical' financing (aiming for disease-specific results) and 'horizontal' financing (aiming for improved health systems) of health services in developing countries has found its way to the pages of Foreign Affairs and the Financial Times. The opportunity offered by 'diagonal' financing (aiming for disease-specific results through improved health systems) seems to be obscured in this p…
No prominent works on this page.
The 'diagonal' approach to Global Fund financing
BACKGROUND: The potentially destructive polarisation between 'vertical' financing (aiming for disease-specific results) and 'horizontal' financing (aiming for improved health systems) of health services in developing countries has found its way to the pages of Foreign Affairs and the Financial Times. The opportunity offered by 'diagonal' financing (aiming for disease-specific results through improved health systems) seems to be obscured in this p…
Patents, Pricing, and Access to Essential Medicines in Developing Countries
A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit
Using global health initiatives to strengthen health systems
Research into the effects of global health initiatives (GHIs) on health systems has largely left out the viewpoints and contributions of civil society. This study details civil society's perspective regarding the effects of two GHIs, the US President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), on country health systems and the added value of civil society interacting with GHIs to …
Evolving Human Rights and the Science of Antiretroviral Medicine
Recent years have seen significant advances in the science of using antiretroviral medicines (ARVs) to fight HIV. Where not long ago ARVs were used late in disease to prevent sick people from dying, today people living with HIV can use ARVs to achieve viral suppression early in the course of disease. This article reviews the mounting new scientific evidence of major clinical and prevention ARV benefits. This has changed the logic of the AIDS resp…
A pandemic treaty for equitable global access to medical countermeasures
Pandemic, Need to know, Biotechnology and Related Fields, Science, Research, and Medicine, Biomedical Ethics and Regulation
Pandemic preparedness and response
Nationalism has trumped solidarity, resulting in unnecessary loss of life and inequitable access to vaccines and therapeutics. Existing intellectual property (IP) regimens, trade secrets and data rights, under which pharmaceutical firms operate, have also posed obstacles to increasing manufacturing capacity, and ensuring adequate supply, affordable pricing, and equitable access to COVID-19 vaccines and other health products in low-income and midd…
Business (5 works) · Political science (5 works) · Economic growth (4 works) · Intellectual property (4 works) · Law (4 works) · Medicine (4 works) · Economics (3 works) · Health care (3 works) · Pharmaceutical Economics and Policy (3 works) · Public relations (3 works)